BNF:

4.3.3

Status:

Do Not Prescribe (DNP), Grey - after consultant/specialist initiation, Green

Decision Date:

March 2017

Comments

GREEN: for use in adults

GREEN: Alternative options if 1^st line options are not suitable for the treatment of chronic primary pain. See non-malignant chronic pain in primary care guidance. 

GREY after consultant/specialist initiation 2^nd line use in children as per NICE (Decision date - June 2018)

Cost effective to prescribe generically.

DO NOT PRESCRIBE (DNP): Not to be prescribed by brand - Lustral. (Decision date - August 2019)

search again